Ligand Pharmaceuticals
LGND
#4056
Rank
A$3.56 B
Marketcap
$188.43
Share price
-1.10%
Change (1 day)
69.92%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.45. In 2022 the company made an earnings per share (EPS) of -$3.09 a decrease over its 2021 EPS that were of $5.40.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-176.37%
2022-$3.09-157.23%
2021$5.40-2571.43%
2020-$0.22-100.46%
2019$47.80353.48%
2018$10.541025%
2017$0.94-700%
2016-$0.16-100.87%
2015$18.051859.32%
2014$0.925.36%
2013$0.878.0704505322479E+18%
2012$0.0000000000-100%
2011$0.77-194.23%
2010-$0.81548.38%
2009-$0.13-98.7%
2008-$9.65-136.52%
2007$26.42-787.8%
2006-$3.84-14.58%
2005-$4.50-21.31%
2004-$5.72-55.15%
2003-$12.7481.33%
2002-$7.032.74%
2001-$6.84-45.93%
2000-$12.65-14.56%
1999-$14.80-45.52%
1998-$27.17-3.97%
1997-$28.29132.31%
1996-$12.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.10 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.56-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.47 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.84 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.90 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.48 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.20 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.99 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.99 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA